Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4IDD8
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006399 | tRNA metabolic process | 7 | 1 |
GO:0006400 | tRNA modification | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008033 | tRNA processing | 8 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:0101030 | tRNA-guanine transglycosylation | 7 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 158 | 162 | PF00656 | 0.483 |
CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.439 |
CLV_PCSK_KEX2_1 | 406 | 408 | PF00082 | 0.415 |
CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.434 |
CLV_PCSK_PC1ET2_1 | 406 | 408 | PF00082 | 0.415 |
CLV_PCSK_SKI1_1 | 346 | 350 | PF00082 | 0.492 |
CLV_PCSK_SKI1_1 | 361 | 365 | PF00082 | 0.438 |
CLV_PCSK_SKI1_1 | 423 | 427 | PF00082 | 0.503 |
DOC_ANK_TNKS_1 | 211 | 218 | PF00023 | 0.597 |
DOC_CKS1_1 | 375 | 380 | PF01111 | 0.492 |
DOC_CYCLIN_RxL_1 | 367 | 377 | PF00134 | 0.492 |
DOC_MAPK_gen_1 | 150 | 159 | PF00069 | 0.446 |
DOC_MAPK_gen_1 | 326 | 335 | PF00069 | 0.433 |
DOC_MAPK_gen_1 | 406 | 414 | PF00069 | 0.492 |
DOC_MAPK_MEF2A_6 | 150 | 159 | PF00069 | 0.415 |
DOC_MAPK_NFAT4_5 | 152 | 160 | PF00069 | 0.432 |
DOC_PP1_RVXF_1 | 128 | 134 | PF00149 | 0.466 |
DOC_PP1_RVXF_1 | 368 | 375 | PF00149 | 0.393 |
DOC_PP2B_LxvP_1 | 144 | 147 | PF13499 | 0.527 |
DOC_PP2B_LxvP_1 | 181 | 184 | PF13499 | 0.487 |
DOC_PP2B_LxvP_1 | 349 | 352 | PF13499 | 0.438 |
DOC_PP4_FxxP_1 | 63 | 66 | PF00568 | 0.647 |
DOC_USP7_MATH_1 | 124 | 128 | PF00917 | 0.546 |
DOC_USP7_MATH_1 | 21 | 25 | PF00917 | 0.458 |
DOC_USP7_MATH_1 | 260 | 264 | PF00917 | 0.571 |
DOC_USP7_MATH_1 | 278 | 282 | PF00917 | 0.517 |
DOC_USP7_MATH_1 | 302 | 306 | PF00917 | 0.661 |
DOC_WW_Pin1_4 | 139 | 144 | PF00397 | 0.456 |
DOC_WW_Pin1_4 | 226 | 231 | PF00397 | 0.482 |
DOC_WW_Pin1_4 | 265 | 270 | PF00397 | 0.609 |
DOC_WW_Pin1_4 | 374 | 379 | PF00397 | 0.475 |
LIG_14-3-3_CanoR_1 | 166 | 171 | PF00244 | 0.506 |
LIG_14-3-3_CanoR_1 | 298 | 302 | PF00244 | 0.546 |
LIG_14-3-3_CanoR_1 | 361 | 366 | PF00244 | 0.438 |
LIG_14-3-3_CanoR_1 | 381 | 386 | PF00244 | 0.418 |
LIG_14-3-3_CanoR_1 | 407 | 412 | PF00244 | 0.390 |
LIG_APCC_ABBA_1 | 333 | 338 | PF00400 | 0.492 |
LIG_APCC_ABBA_1 | 60 | 65 | PF00400 | 0.500 |
LIG_BRCT_BRCA1_1 | 306 | 310 | PF00533 | 0.486 |
LIG_CSL_BTD_1 | 144 | 147 | PF09270 | 0.445 |
LIG_DLG_GKlike_1 | 166 | 173 | PF00625 | 0.522 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.430 |
LIG_FHA_1 | 51 | 57 | PF00498 | 0.659 |
LIG_FHA_2 | 226 | 232 | PF00498 | 0.565 |
LIG_FHA_2 | 298 | 304 | PF00498 | 0.544 |
LIG_FHA_2 | 390 | 396 | PF00498 | 0.429 |
LIG_Integrin_RGD_1 | 119 | 121 | PF01839 | 0.598 |
LIG_LIR_Apic_2 | 321 | 325 | PF02991 | 0.357 |
LIG_LIR_Apic_2 | 61 | 66 | PF02991 | 0.659 |
LIG_LIR_Gen_1 | 209 | 218 | PF02991 | 0.624 |
LIG_LIR_Nem_3 | 168 | 174 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 209 | 213 | PF02991 | 0.579 |
LIG_LIR_Nem_3 | 30 | 35 | PF02991 | 0.496 |
LIG_PAM2_1 | 273 | 285 | PF00658 | 0.699 |
LIG_Pex14_2 | 110 | 114 | PF04695 | 0.516 |
LIG_PTAP_UEV_1 | 274 | 279 | PF05743 | 0.757 |
LIG_RPA_C_Fungi | 161 | 173 | PF08784 | 0.518 |
LIG_SH2_CRK | 171 | 175 | PF00017 | 0.470 |
LIG_SH2_CRK | 322 | 326 | PF00017 | 0.357 |
LIG_SH2_CRK | 424 | 428 | PF00017 | 0.438 |
LIG_SH2_NCK_1 | 36 | 40 | PF00017 | 0.499 |
LIG_SH2_SRC | 322 | 325 | PF00017 | 0.391 |
LIG_SH2_SRC | 336 | 339 | PF00017 | 0.391 |
LIG_SH2_STAP1 | 207 | 211 | PF00017 | 0.485 |
LIG_SH2_STAP1 | 336 | 340 | PF00017 | 0.438 |
LIG_SH2_STAP1 | 416 | 420 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 420 | 423 | PF00017 | 0.401 |
LIG_SH2_STAT5 | 96 | 99 | PF00017 | 0.464 |
LIG_SH3_1 | 272 | 278 | PF00018 | 0.651 |
LIG_SH3_3 | 212 | 218 | PF00018 | 0.595 |
LIG_SH3_3 | 272 | 278 | PF00018 | 0.742 |
LIG_SH3_3 | 36 | 42 | PF00018 | 0.502 |
LIG_SH3_3 | 394 | 400 | PF00018 | 0.477 |
LIG_SUMO_SIM_anti_2 | 151 | 158 | PF11976 | 0.491 |
LIG_SUMO_SIM_par_1 | 1 | 6 | PF11976 | 0.480 |
LIG_SUMO_SIM_par_1 | 154 | 161 | PF11976 | 0.439 |
LIG_SUMO_SIM_par_1 | 58 | 65 | PF11976 | 0.495 |
LIG_TRAF2_1 | 354 | 357 | PF00917 | 0.438 |
MOD_CDK_SPxxK_3 | 265 | 272 | PF00069 | 0.546 |
MOD_CDK_SPxxK_3 | 374 | 381 | PF00069 | 0.454 |
MOD_CK1_1 | 241 | 247 | PF00069 | 0.478 |
MOD_CK1_1 | 262 | 268 | PF00069 | 0.648 |
MOD_CK1_1 | 281 | 287 | PF00069 | 0.454 |
MOD_CK1_1 | 297 | 303 | PF00069 | 0.769 |
MOD_CK1_1 | 304 | 310 | PF00069 | 0.385 |
MOD_CK1_1 | 43 | 49 | PF00069 | 0.634 |
MOD_CK2_1 | 21 | 27 | PF00069 | 0.539 |
MOD_CK2_1 | 290 | 296 | PF00069 | 0.580 |
MOD_CK2_1 | 297 | 303 | PF00069 | 0.605 |
MOD_CK2_1 | 351 | 357 | PF00069 | 0.492 |
MOD_CK2_1 | 389 | 395 | PF00069 | 0.429 |
MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.547 |
MOD_GlcNHglycan | 262 | 265 | PF01048 | 0.569 |
MOD_GlcNHglycan | 275 | 278 | PF01048 | 0.696 |
MOD_GlcNHglycan | 292 | 295 | PF01048 | 0.557 |
MOD_GlcNHglycan | 306 | 309 | PF01048 | 0.410 |
MOD_GlcNHglycan | 312 | 315 | PF01048 | 0.382 |
MOD_GlcNHglycan | 353 | 356 | PF01048 | 0.415 |
MOD_GlcNHglycan | 45 | 48 | PF01048 | 0.639 |
MOD_GlcNHglycan | 67 | 70 | PF01048 | 0.737 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.505 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.490 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.528 |
MOD_GSK3_1 | 222 | 229 | PF00069 | 0.664 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.556 |
MOD_GSK3_1 | 290 | 297 | PF00069 | 0.685 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.203 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.683 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.430 |
MOD_NEK2_1 | 238 | 243 | PF00069 | 0.465 |
MOD_NEK2_1 | 310 | 315 | PF00069 | 0.395 |
MOD_NEK2_1 | 434 | 439 | PF00069 | 0.350 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.457 |
MOD_PIKK_1 | 238 | 244 | PF00454 | 0.473 |
MOD_PK_1 | 407 | 413 | PF00069 | 0.317 |
MOD_PKA_2 | 165 | 171 | PF00069 | 0.510 |
MOD_PKA_2 | 297 | 303 | PF00069 | 0.544 |
MOD_PKA_2 | 380 | 386 | PF00069 | 0.371 |
MOD_PKA_2 | 88 | 94 | PF00069 | 0.419 |
MOD_PKB_1 | 117 | 125 | PF00069 | 0.488 |
MOD_Plk_1 | 302 | 308 | PF00069 | 0.685 |
MOD_Plk_1 | 356 | 362 | PF00069 | 0.393 |
MOD_Plk_4 | 166 | 172 | PF00069 | 0.432 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.473 |
MOD_Plk_4 | 278 | 284 | PF00069 | 0.656 |
MOD_Plk_4 | 361 | 367 | PF00069 | 0.430 |
MOD_Plk_4 | 407 | 413 | PF00069 | 0.317 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.548 |
MOD_ProDKin_1 | 139 | 145 | PF00069 | 0.457 |
MOD_ProDKin_1 | 226 | 232 | PF00069 | 0.468 |
MOD_ProDKin_1 | 265 | 271 | PF00069 | 0.613 |
MOD_ProDKin_1 | 374 | 380 | PF00069 | 0.475 |
TRG_DiLeu_BaEn_1 | 151 | 156 | PF01217 | 0.492 |
TRG_DiLeu_BaLyEn_6 | 367 | 372 | PF01217 | 0.438 |
TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.485 |
TRG_ENDOCYTIC_2 | 207 | 210 | PF00928 | 0.433 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.409 |
TRG_ER_diArg_1 | 98 | 100 | PF00400 | 0.443 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P722 | Leptomonas seymouri | 52% | 83% |
A0A1X0P849 | Trypanosomatidae | 34% | 100% |
A0A3Q8INL6 | Leishmania donovani | 99% | 81% |
A4HP31 | Leishmania braziliensis | 76% | 100% |
D0A314 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 88% |
E9AST9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q1Q7 | Leishmania major | 92% | 100% |